Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 100806
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.100806
Table 1 Baseline characteristics of study participants, n (%)
Characteristic
Intervention group (n = 100)
Control group (n = 100)
P value
Age, years (mean ± SD)73.5 ± 6.274.1 ± 5.90.47
Male sex58 (58)55 (55)0.67
BMI, kg/m² (mean ± SD)24.3 ± 3.824.7 ± 4.10.46
APACHE II score (mean ± SD)18.3 ± 5.717.9 ± 6.10.63
Type of surgery
Gastric28 (28)30 (30)0.75
Colorectal45 (45)42 (42)0.67
Hepatobiliary18 (18)20 (20)0.72
Pancreatic9 (9)8 (8)0.80
Comorbidities
Hypertension62 (62)59 (59)0.66
Diabetes mellitus35 (35)38 (38)0.66
Coronary artery disease28 (28)25 (25)0.63
COPD15 (15)18 (18)0.57
Chronic kidney disease12 (12)10 (10)0.65
Mechanical ventilation78 (78)75 (75)0.61
Vasopressor use45 (45)48 (48)0.67
Table 2 Secondary outcomes, n (%)
Outcome
Intervention group (n = 100)
Control group (n = 100)
P value
Ulcer healing time, days (mean ± SD)15.2 ± 2.17.8 ± 3.40.003
Stress ulcer-related complications3 (3)9 (9)0.04
Length of ICU stay, days [median (IQR)]5 [3-8]7 [4-11]0.01
Length of hospital stay, days (mean ± SD)12.3 ± 5.615.7 ± 7.20.001
30-day mortality8 (8)13 (13)0.25
Ventilator-associated pneumonia7 (7)15 (15)0.07
Clostridium difficile infection2 (2)5 (5)0.25
Table 3 Incidence of stress ulcers by risk category, n (%)
Risk category
Intervention group
Control group
P value
Low risk2/35 (5.7)4/33 (12.1)0.35
Moderate risk6/42 (14.3)13/45 (28.9)0.09
High risk7/23 (30.4)13/22 (59.1)0.05